CN102247486B - Bone health care marrow filling capsule - Google Patents
Bone health care marrow filling capsule Download PDFInfo
- Publication number
- CN102247486B CN102247486B CN2011102217796A CN201110221779A CN102247486B CN 102247486 B CN102247486 B CN 102247486B CN 2011102217796 A CN2011102217796 A CN 2011102217796A CN 201110221779 A CN201110221779 A CN 201110221779A CN 102247486 B CN102247486 B CN 102247486B
- Authority
- CN
- China
- Prior art keywords
- health care
- marrow
- bone
- filling capsule
- bone health
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 10
- 230000037180 bone health Effects 0.000 title abstract 7
- 239000003814 drug Substances 0.000 claims abstract description 31
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 19
- 229940079593 drug Drugs 0.000 claims abstract description 15
- 239000002994 raw material Substances 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 26
- 210000004369 blood Anatomy 0.000 abstract description 8
- 239000008280 blood Substances 0.000 abstract description 8
- 208000001132 Osteoporosis Diseases 0.000 abstract description 7
- 210000003038 endothelium Anatomy 0.000 abstract description 7
- 238000005728 strengthening Methods 0.000 abstract description 6
- 206010039984 Senile osteoporosis Diseases 0.000 abstract description 4
- 210000002435 tendon Anatomy 0.000 abstract description 2
- 241000427159 Achyranthes Species 0.000 abstract 1
- 241000123589 Dipsacus Species 0.000 abstract 1
- 241001116742 Drynaria Species 0.000 abstract 1
- 241000208689 Eucommia ulmoides Species 0.000 abstract 1
- 240000007049 Juglans regia Species 0.000 abstract 1
- 235000009496 Juglans regia Nutrition 0.000 abstract 1
- 244000241838 Lycium barbarum Species 0.000 abstract 1
- 235000015459 Lycium barbarum Nutrition 0.000 abstract 1
- 235000015468 Lycium chinense Nutrition 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 241000405414 Rehmannia Species 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 230000036299 sexual function Effects 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 239000003053 toxin Substances 0.000 abstract 1
- 231100000765 toxin Toxicity 0.000 abstract 1
- 108700012359 toxins Proteins 0.000 abstract 1
- 235000020234 walnut Nutrition 0.000 abstract 1
- 210000003734 kidney Anatomy 0.000 description 30
- 210000004185 liver Anatomy 0.000 description 14
- 210000003205 muscle Anatomy 0.000 description 11
- 201000010099 disease Diseases 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 239000010271 massa medicata fermentata Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 210000000582 semen Anatomy 0.000 description 6
- 238000007791 dehumidification Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 201000003068 rheumatic fever Diseases 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010013786 Dry skin Diseases 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 208000013403 hyperactivity Diseases 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 239000002671 adjuvant Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 231100000862 numbness Toxicity 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000590988 Danainae Species 0.000 description 1
- 241000201295 Euphrasia Species 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000521257 Hydrops Species 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 230000004097 bone metabolism Effects 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 238000004320 controlled atmosphere Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000003163 gonadal steroid hormone Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000004409 osteocyte Anatomy 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical compound OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention relates to a bone health care marrow filling capsule, disclosing a bone health care marrow filling capsule. In the bone health care marrow filling capsule, 12 types of medicines, such as bone fat, herba epimedii, Eucommia ulmoides, walnut, teasel root, rehmannia, barbary wolfberry fruit, drynaria rhizome, endothelium corneum gigeriae galli, oyster, medicated leaven and the root of bidentate achyranthes serve as bulk pharmaceutical chemicals and are smashed, decocted, condensed, dried, screened and the like to obtain the bone health care marrow filling capsule. The bone health care marrow filling capsule has the peculiar curative effect on enhancing sexual functions, eliminating toxins, lowering blood lipid, replenishing essence, replenishing marrow, compacting bone and strengthening tendon. The bone health care marrow filling capsule is clinically applied to rheumatoid arthritis, senile osteoporosis and the like, has exact curative effect, obvious effect and no toxic or side effect and is safe and effective Chinese medicine formula.
Description
Technical field
The invention belongs to Chinese medicine, relate to and a kind ofly be applied to traditional Chinese medical science orthopaedics, have kidney invigorating and YANG supporting, dispelling cold and dehumidification, benefiting essence and marrow, the Chinese medicine preparation of the effect of the strong muscle of close bone.
Background technology
Rheumatic arthritis is comparatively common clinically acute or chronic ICT, can show effect repeatedly and involves heart.Miserable with joint and muscle the. fugitive clinically, heavily outstanding, pain is characteristic.It is as one of main performance of rheumatic fever, how with febris acuta and arthralgia onset.Senile osteoporosis then is a kind of systemic osteopathia, and the fine structure that it is characterized by decline of bone amount and bone destroys, and clinical manifestation is that the fragility of bone increases, even also fracture easily under slight wound or the atraumatic situation.Though rheumatic arthritis and senile osteoporosis etiology and pathogenesis are had nothing in common with each other; But similarity is arranged but aspect clinical manifestation; Patient's majority shows as limited, the arthroncus of action, hydrops, local tingle pain; Bone joint degeneration appears in the patient that part is serious, even is unable to leave the bed, and causes severe complications.On the one hand, the cause of disease is various, pathology is complicated because two kinds of diseases have, thereby causes single western medicine to be difficult to reach ideal therapeutic effect, can make the state of an illness obtain temporary transient alleviation, but the limitation and the side effect of treatment also are conspicuous.On the other hand, still do not have the special effect Chinese of two kinds of diseases of treatment clinically, it is mostly opened according to prescription according to traditional Chinese medical science doctor's experience, and adopts traditional method to carry out decoction, and technology is simple, and is backward in technique, and effect of drugs is difficult to guarantee.
Summary of the invention
The purpose of this invention is to provide a kind of new kidney invigorating and YANG supporting that has, dispelling cold and dehumidification, benefiting essence and marrow, the medicine of the strong muscle effect of close bone, technical scheme of the present invention is characterised in that it is that primary raw material medicine by the following weight proportioning forms by the conventional formulation prepared:
Optimum weight part proportioning of the present invention is:
Theory of Chinese medical science thinks, it is one of sick that rheumatic arthritis belongs to common numbness, and it is often because human feeling's wind, cold, damp and dedicate one's life to pain or heavy sensation of the body, arthralgia, joint stuffiness.Osteoporosis is as the commonly encountered diseases of mid-aged population, mainly due to advancing age, its sex hormone secretion in vivo reduce and the calcium-regulating hormone dyssecretosis due to.To the above cause of disease, the present invention has selected for use has kidney invigorating and YANG supporting, dispelling cold and dehumidification, benefiting essence and marrow, the drug matching of the strong muscle effect of close bone.Herba Epimedii in the side, the Cortex Eucommiae, Fructus Psoraleae, Semen Juglandis are monarch drug.Herba Epimedii, acrid in the mouth is warm in nature, returns liver, stomach warp, the function kidney invigorating and YANG supporting, dispelling cold and dehumidification is for preventing and treating the osteoporosis key medicine.The Cortex Eucommiae, the sweet in the mouth temperature is gone into the Liver and kidney warp, the ability liver and kidney tonifying, strong waist knee joint, strengthening bone and muscle are for controlling the key medicine of lumbago.Fructus Psoraleae, arduous big temperature is returned kidney, spleen channel, is longer than kidney invigorating and YANG supporting, warming spleen and stopping diarrha, helping inspiration to relieve asthma, be the medicine of spleen kidney and benefits, can warming the kidney, give birth in the moon positive, the key medicine of the beneficial soil of excessive fire.Fructus Psoraleae is hot, hardship, and temperature is returned the kidney spleen channel, has the effect of warming the kidney to activate YANG, and effect is a replenishing kidney, strengthening waist.Semen Juglandis, the sweet temperature of property is returned lung, kidney essense, tonifying the lung, Dingchuan, bone and muscle strengthening, loosening bowel to relieve constipation, the logical gate of vitality, sharp three warmers, benefiting QI and nourishing blood is all the medicine of mending the part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels, kidney, the gate of vitality with Fructus Psoraleae.Four flavor monarchs drug can not only effectively suppress the bone resorption activity of osteocyte, can also strengthen the generation osteoblast, produce more bone matrix, make the bone metabolism balance, with four medicines phase 5, can be used for osteoporosis.Ministerial drug is a Radix Rehmanniae in the side, Fructus Lycii, Rhizoma Drynariae, Radix Dipsaci.Radix Rehmanniae, sweetness and bitterness is slightly cold, GUIXIN, liver, kidney channel.The effect nourishing YIN of nourishing blood, property is flat, and is not cold and cool partially, and nourish blood and very do not grow greasyly, be the key medicine of the kidney invigorating man.Fructus Lycii, sweet flat, return liver, kidney channel.The effect replenishing vital essence and blood, liver and kidney tonifying makes eye bright, and its pliable and tough many liquid are replenishing vital essence and blood, the key medicine of liver and kidney tonifying.Rhizoma Drynariae, bitter, warm, reunion of fractured tendons and bones, liver and kidney tonifying.Radix Dipsaci, bitter, sweet, tepor are returned liver, kidney channel, effect invigorating the liver and kidney, promoting blood circulation, bone and muscle strengthening, pain relieving.Four ministerial drugs, life essence-filling, marrow-benefitting, coronary circulation-promoting pain-relieving can be alleviated the inclined to one side using warming therapy property of monarch drug, can strengthen the power of monarch drug tonification again.Adjuvant drug is an Endothelium Corneum Gigeriae Galli in the side, Concha Ostreae, Massa Medicata Fermentata.Endothelium Corneum Gigeriae Galli, sweet in the mouth property is flat, returns taste, small intestinal, urinary bladder channel, and effect helps digestion for long-pending, and the controlling nocturnal emission with astringent drugs reducing urination is for hard Sal Nitri.Massa Medicata Fermentata, sweet, hot, warm, return spleen, stomach warp, help digestion stomach function regulating detoxifcation of effect is loose in the controlled atmosphere, and the kidney warming is for expectorant, and relieving oedema or abdominal distension through diuresis or purgation, it is stagnant to disappear.Concha Ostreae is distinguished the flavor of into puckeryly, and property is floating, returns the Liver and kidney warp, effect yin fluid astringing YANG hyperactivity suppressing, and the hidroschesis arresting seminal emission, the article of Aquatic product, many property are cloudy and the property of the sun of educating is arranged, and press down floating yang hyperactivity Sheng, suppressing the hyperactive liver to relieve the wind syndrome.Three flavor adjuvant drugs, stomach function regulating helps fortuneization, Yin Yang balancing.Messenger drug is a Radix Achyranthis Bidentatae in the side, and the property picric acid is flat, returns liver, kidney channel, and the effect blood stasis dispelling stimulates the menstrual flow, conducting blood to flow downwards, sharp joint.Herba Epimedii, the Cortex Eucommiae, Fructus Psoraleae, Semen Juglandis, kidney invigorating and YANG supporting in the side.Radix Rehmanniae, Fructus Lycii, YIN nourishing replenishing essence; Rhizoma Drynariae, wear Radix Dipsaci invigorating the liver and kidney, bone and muscle strengthening, stopping numbness pain, assistant is with Concha Ostreae, yin fluid astringing YANG hyperactivity suppressing collateral dredging, Endothelium Corneum Gigeriae Galli, Massa Medicata Fermentata and in protect stomach, help fortuneization, the strong muscle of Radix Achyranthis Bidentatae is invigorated blood circulation, priming is descending.Full side plays benefiting essence and marrow, the effect of the strong muscle of close bone altogether.
The present invention is to be the basis with the theory of Chinese medical science, the medicine formulated according to the performance of Chinese medicine.It adopts the conventional Chinese medicine material as raw material, has kidney invigorating and YANG supporting, dispelling cold and dehumidification, benefiting essence and marrow, unique curative effect of the strong muscle of close bone.Clinical practice is in diseases such as rheumatic arthritis and senile osteoporosises, determined curative effect, and effect is remarkable, and has no side effect, and is an effective Chinese medicinal formulae as safe as a house.
Below provide clinical data, with proof the present invention's curative effect.Totally 500 examples, male patient's 215 examples wherein, female patient 285 examples, between 26～82 years old age, the course of disease 2 months～5 years.Instructions of taking: every day 3 times, each 6,10 days is a course of treatment, observes 3 courses of treatment.
The clinical statistics table
Criterion of therapeutical effect
The specific embodiment
One, above 12 flavors are got Fructus Psoraleae 40g and are ground into fine powder, and all the other ten add residue Fructus Psoraleae 40g and Herba Epimedii 160g, Cortex Eucommiae 80g, Semen Juglandis 80g, Radix Dipsaci 80g, Radix Rehmanniae 160g, Fructus Lycii 80g, Rhizoma Drynariae 80g, Endothelium Corneum Gigeriae Galli 180g, Concha Ostreae 180g, Massa Medicata Fermentata 180g, Radix Achyranthis Bidentatae 100g etc. 10 times of decoctings simply and boil twice; Each 2 hours, filter merging filtrate; Place, get supernatant concentration and become thick paste, add above-mentioned fine powder; Stir 60 ℃ of dryings, 80 order crushing screenings; Incapsulate, process 800, promptly get.
Two, above 12 flavors are got Fructus Psoraleae 300g and are ground into fine powder, and all the other ten add residue Fructus Psoraleae 300g and Herba Epimedii 1000g, Cortex Eucommiae 600g, Semen Juglandis 600g, Radix Dipsaci 600g, Radix Rehmanniae 1000g, Fructus Lycii 600g, Rhizoma Drynariae 600g, Endothelium Corneum Gigeriae Galli 1000g, Concha Ostreae 1000g, Massa Medicata Fermentata 1000g, Radix Achyranthis Bidentatae 600g etc. 10 times of decoctings simply and boil twice; Each 2 hours, filter merging filtrate; Place, get supernatant concentration and become thick paste, add above-mentioned fine powder; Stir 60 ℃ of dryings, 80 order crushing screenings; Incapsulate, process 5000, promptly get.
Three, above 12 flavors are got Fructus Psoraleae 800g and are ground into fine powder, and all the other ten add residue Fructus Psoraleae 800g and Herba Epimedii 2400g, Cortex Eucommiae 1600g, Semen Juglandis 1600g, Radix Dipsaci 1600g, Radix Rehmanniae 2400g, Fructus Lycii 1600g, Rhizoma Drynariae 1600g, Endothelium Corneum Gigeriae Galli 2200g, Concha Ostreae 2200g, Massa Medicata Fermentata 2200g, Radix Achyranthis Bidentatae 1400g etc. 10 times of decoctings simply and boil twice; Each 2 hours, filter merging filtrate; Place, get supernatant concentration and become thick paste, add above-mentioned fine powder; Stir 60 ℃ of dryings, 80 order crushing screenings; Incapsulate, process 12500, promptly get.
Claims (2)
1. strong bone is filled out the marrow capsule, it is characterized in that it being to be formed by the conventional formulation prepared by following raw materials by weight proportions:
2. strong bone according to claim 1 is filled out the marrow capsule, it is characterized in that the weight proportion of each crude drug is:
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102217796A CN102247486B (en) | 2011-08-04 | 2011-08-04 | Bone health care marrow filling capsule |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011102217796A CN102247486B (en) | 2011-08-04 | 2011-08-04 | Bone health care marrow filling capsule |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102247486A CN102247486A (en) | 2011-11-23 |
| CN102247486B true CN102247486B (en) | 2012-11-07 |
Family
ID=44975290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011102217796A Expired - Fee Related CN102247486B (en) | 2011-08-04 | 2011-08-04 | Bone health care marrow filling capsule |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102247486B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079403B (en) * | 2015-09-14 | 2019-01-08 | 丽水市农业科学研究院 | Chinese medicine composition and preparation method thereof for treating osteoporosis |
| CN105126042A (en) * | 2015-10-24 | 2015-12-09 | 黄宇松 | Medicine composition for treating osteoporosis |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1660404A (en) * | 2005-01-19 | 2005-08-31 | 雷小平 | Health product of preserving health, invigorating the kidney and supporting yang for male |
| CN101366919A (en) * | 2008-10-08 | 2009-02-18 | 韩涛 | Traditional Chinese medicine ointment for treating rheumatism diseases |
-
2011
- 2011-08-04 CN CN2011102217796A patent/CN102247486B/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1660404A (en) * | 2005-01-19 | 2005-08-31 | 雷小平 | Health product of preserving health, invigorating the kidney and supporting yang for male |
| CN101366919A (en) * | 2008-10-08 | 2009-02-18 | 韩涛 | Traditional Chinese medicine ointment for treating rheumatism diseases |
Non-Patent Citations (1)
| Title |
|---|
| 赖昌生.入肾经中药性能及功效特点的计算机分析.《河南中医》.2010,第30卷(第4期),406－409. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102247486A (en) | 2011-11-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100551422C (en) | A kind of endo-medicine for the treatment of intervertebral disk hernia | |
| CN104353019A (en) | Traditional Chinese medicine hot compress bag with meridian dredging and internal organ conditioning functions and preparation method of traditional Chinese medicine hot compress bag | |
| CN101474288B (en) | Chinese medicine composition for treating wind-cold-dampness induced paralysis | |
| CN104740437A (en) | Traditional Chinese medicine composition for treating constipation and preparation method of traditional Chinese medicine composition | |
| CN102861296B (en) | Pill inducing diuresis and reducing edema for treating gonarthromeningitis | |
| CN104069162A (en) | Traditional Chinese medicine for treating gouty arthritis and various bone and arthrosis pains | |
| CN102247486B (en) | Bone health care marrow filling capsule | |
| CN103599404A (en) | Traditional Chinese medicinal decoction for treating cervical spondylosis | |
| CN104623600A (en) | Traditional Chinese medicine for treating peripheral neuritis and preparation method thereof | |
| CN104721313B (en) | A kind of care drug for the treatment of acute lumbar injury | |
| CN100431595C (en) | Medicinal composition for treating qi stagnation and cold stasis stomach-ache and its preparing method and use | |
| CN103393943A (en) | Traditional Chinese medicine composition for treating sequela of cerebral infarction | |
| CN102579672A (en) | Medicament for treating bone hyperplasia and lumbar disc herniation | |
| CN103599321B (en) | Traditional Chinese medicine composition for treating osteoporosis | |
| CN103202985A (en) | Traditional Chinese medicine used for treating lumbar spondylosis, cervical spondylosis, sciatica and rheumatism and preparation method thereof | |
| CN106039152A (en) | Traditional Chinese medicine preparation for treating acute waist sprain | |
| CN101797291B (en) | Traditional Chinese medicine for treating osteoproliferation | |
| CN102058808A (en) | Traditional Chinese medicament for treating rheumatic arthritis | |
| CN100402077C (en) | Medicinal composition for treating hyperosteogency | |
| CN104225112A (en) | Traditional Chinese medicinal composition for curing osteoarthritis | |
| CN1305518C (en) | Chinese medine for treating paraplegia | |
| CN102836276A (en) | Bone spur softening pill for treating osteoarthritis | |
| CN103893328A (en) | Traditional Chinese medicine pill used for treating hyperplasia of mammary glands | |
| CN103372187A (en) | Medicine for treating urticaria | |
| CN102641348B (en) | Collateral-dredging and pain-relieving powder and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Ligang Inventor after: Xu Hui Inventor after: Su Yuqin Inventor before: Chen Ligang Inventor before: Su Yuqin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN LIGANG SU YUQIN TO: CHEN LIGANG XU HUI SU YUQIN |
|
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Ligang Inventor after: Xu Hui Inventor after: Su Yuqin Inventor after: Ren Honglin Inventor before: Chen Ligang Inventor before: Xu Hui Inventor before: Su Yuqin |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CHEN LIGANG XU HUI SU YUQIN TO: CHEN LIGANG XU HUI SU YUQIN REN HONGLIN |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121107 Termination date: 20210804 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |